Related Experiment Video

Updated: May 31, 2026

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

Bispecific Antibody Therapy With Elranatamab for Refractory Waldenström Macroglobulinemia: A Case Report

Varun Nandakumar1, Amandeep Godara1, Felix Mensah2

  • 1Department of Hematology and Oncology, Hematology and Hematologic Malignancies, Huntsman Cancer Institute, Salt Lake, UT.

Clinical Lymphoma, Myeloma & Leukemia
|May 29, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
B-cell maturation antigen (BCMA)BiTEBispecific antibodiesTeclistamab

More Related Videos

A BW Reporter System for Studying Receptor-Ligand Interactions06:05

A BW Reporter System for Studying Receptor-Ligand Interactions

Published on: January 7, 2019

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Related Concept Videos